Charles Schwab Investment Management Inc Nevro Corp Transaction History

Charles Schwab Investment Management Inc

  • $515 Billion
  • Q3 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Nevro Corp stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 303,675 shares of NVRO stock, worth $1.37 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
303,675
Previous 292,306 3.89%
Holding current value
$1.37 Million
Previous $2.46 Million 31.17%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$4.71 - $10.1 $53,547 - $114,826
11,369 Added 3.89%
303,675 $1.69 Million
Q2 2024

Aug 12, 2024
BUY
$7.96 - $13.59 $345,559 - $589,969
43,412 Added 17.44%
292,306 $2.46 Million
Q1 2024

May 08, 2024
SELL
$13.56 - $20.78 $428,957 - $657,354
-31,634 Reduced 11.28%
248,894 $3.59 Million
Q4 2023

Feb 06, 2024
BUY
$14.18 - $22.31 $54,734 - $86,116
3,860 Added 1.4%
280,528 $6.04 Million
Q3 2023

Nov 08, 2023
BUY
$18.22 - $25.85 $179,394 - $254,519
9,846 Added 3.69%
276,668 $5.32 Million
Q2 2023

Aug 09, 2023
BUY
$22.62 - $39.32 $95,705 - $166,362
4,231 Added 1.61%
266,822 $6.78 Million
Q1 2023

May 11, 2023
BUY
$30.17 - $41.11 $13,063 - $17,800
433 Added 0.17%
262,591 $9.49 Million
Q4 2022

Feb 13, 2023
BUY
$36.43 - $49.4 $252,860 - $342,885
6,941 Added 2.72%
262,158 $10.4 Million
Q3 2022

Nov 14, 2022
BUY
$40.66 - $53.03 $250,790 - $327,089
6,168 Added 2.48%
255,217 $11.9 Million
Q2 2022

Aug 15, 2022
SELL
$40.85 - $77.67 $168,833 - $321,010
-4,133 Reduced 1.63%
249,049 $10.9 Million
Q1 2022

May 13, 2022
BUY
$59.95 - $92.06 $433,858 - $666,238
7,237 Added 2.94%
253,182 $18.3 Million
Q4 2021

Feb 11, 2022
BUY
$81.07 - $121.29 $268,665 - $401,955
3,314 Added 1.37%
245,945 $19.9 Million
Q3 2021

Nov 16, 2021
SELL
$101.99 - $166.36 $1.3 Million - $2.13 Million
-12,774 Reduced 5.0%
242,631 $28.2 Million
Q2 2021

Aug 16, 2021
BUY
$141.6 - $179.06 $757,418 - $957,791
5,349 Added 2.14%
255,405 $42.3 Million
Q1 2021

May 17, 2021
BUY
$132.81 - $182.18 $2.23 Million - $3.06 Million
16,778 Added 7.19%
250,056 $34.9 Million
Q4 2020

Feb 16, 2021
BUY
$138.17 - $184.34 $381,763 - $509,331
2,763 Added 1.2%
233,278 $40.4 Million
Q3 2020

Nov 13, 2020
SELL
$114.09 - $145.51 $652,708 - $832,462
-5,721 Reduced 2.42%
230,515 $32.1 Million
Q2 2020

Aug 14, 2020
BUY
$89.45 - $129.85 $3.96 Million - $5.74 Million
44,222 Added 23.03%
236,236 $28.2 Million
Q1 2020

May 15, 2020
BUY
$70.23 - $144.31 $266,522 - $547,656
3,795 Added 2.02%
192,014 $19.2 Million
Q4 2019

Feb 07, 2020
BUY
$76.41 - $117.54 $311,217 - $478,740
4,073 Added 2.21%
188,219 $22.1 Million
Q3 2019

Nov 08, 2019
BUY
$61.52 - $91.1 $453,094 - $670,951
7,365 Added 4.17%
184,146 $15.8 Million
Q2 2019

Aug 09, 2019
BUY
$58.04 - $66.99 $278,650 - $321,618
4,801 Added 2.79%
176,781 $11.5 Million
Q1 2019

May 14, 2019
BUY
$35.52 - $62.62 $265,760 - $468,522
7,482 Added 4.55%
171,980 $10.8 Million
Q4 2018

Feb 14, 2019
BUY
$35.43 - $56.29 $26,076 - $41,429
736 Added 0.45%
164,498 $6.4 Million
Q3 2018

Nov 13, 2018
BUY
$44.22 - $75.47 $727,993 - $1.24 Million
16,463 Added 11.18%
163,762 $9.34 Million
Q2 2018

Aug 08, 2018
BUY
$72.38 - $92.5 $663,941 - $848,502
9,173 Added 6.64%
147,299 $11.8 Million
Q1 2018

May 07, 2018
BUY
$69.46 - $88.57 $495,874 - $632,301
7,139 Added 5.45%
138,126 $12 Million
Q4 2017

Jan 17, 2018
BUY
$65.94 - $93.31 $22,749 - $32,191
345 Added 0.26%
130,987 $9.04 Million
Q3 2017

Nov 13, 2017
BUY
$80.87 - $91.08 $10.6 Million - $11.9 Million
130,642
130,642 $11.9 Million

Others Institutions Holding NVRO

# of Institutions
151
Shares Held
39.3M
Call Options Held
67.9K
Put Options Held
1.59M
View Full List

About NEVRO CORP

NVRO Quotes by TradingView
  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $160M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email